{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:11:51Z","timestamp":1792858311137,"version":"4.5.0"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Inflammasomes are innate immune sensors that regulate caspase-1 mediated inflammation in response to environmental, host- and pathogen-derived factors. The NLRP3 inflammasome is highly versatile as it is activated by a diverse range of stimuli. However, excessive or chronic inflammasome activation and subsequent interleukin-1\u03b2 (IL-1\u03b2) release are implicated in the pathogenesis of various autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, and diabetes. Accordingly, inflammasome inhibitor therapy has a therapeutic benefit in these diseases. In contrast, NLRP3 inflammasome is an important defense mechanism against microbial infections. IL-1\u03b2 antagonizes bacterial invasion and dissemination. Unfortunately, patients receiving IL-1\u03b2 or inflammasome inhibitors are reported to be at a disproportionate risk to experience invasive bacterial infections including pneumococcal infections. Pneumococci are typical colonizers of immunocompromised individuals and a leading cause of community-acquired pneumonia worldwide. Here, we summarize the current limited knowledge of inflammasome activation in pneumococcal infections of the respiratory tract and how inflammasome inhibition may benefit these infections in immunocompromised patients.<\/jats:p>","DOI":"10.3389\/fimmu.2020.614801","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T06:40:35Z","timestamp":1607928035000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["The Role of NLRP3 Inflammasome in Pneumococcal Infections"],"prefix":"10.3389","volume":"11","author":[{"given":"Surabhi","family":"Surabhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Cuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Hammerschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Siemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00849-17","article-title":"The cGAS\/STING Pathway Detects Streptococcus pneumoniae but Appears Dispensable for Antipneumococcal Defense in Mice and Humans","volume":"86","author":"Ruiz-Moreno","year":"2018","journal-title":"Infect Immun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00327","article-title":"NOD-Like Receptors: Master Regulators of Inflammation and Cancer","volume":"5","author":"Saxena","year":"2014","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00570","article-title":"Bacterial Exotoxins and the Inflammasome","volume":"6","author":"Greaney","year":"2015","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12289","article-title":"Bacterial recognition pathways that lead to inflammasome activation","volume":"265","author":"Storek","year":"2015","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4063562","DOI":"10.1155\/2020\/4063562","article-title":"NLRP3 Inflammasome and Inflammatory Diseases","volume":"2020","author":"Wang","year":"2020","journal-title":"Oxid Med Cell Longevity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aah3539","article-title":"IL-1\u03b2 is an innate immune sensor of microbial proteolysis","volume":"1","author":"LaRock","year":"2016","journal-title":"Sci Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1295-z","article-title":"Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome","volume":"570","author":"Sharif","year":"2019","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26252","article-title":"Caspases: pharmacological manipulation of cell death","volume":"115","author":"Lavrik","year":"2005","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41419-019-1938-x","article-title":"TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP","volume":"10","author":"Knop","year":"2019","journal-title":"Cell Death Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700175","article-title":"Cutting Edge: TRAF6 Mediates TLR\/IL-1R Signaling-Induced Nontranscriptional Priming of the NLRP3 Inflammasome","volume":"199","author":"Xing","year":"2017","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J\u00a0Immunol (Baltimore Md 1950)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4049\/jimmunol.1100229","article-title":"Modulation of inflammasome pathways by bacterial and viral pathogens","volume":"187","author":"Lamkanfi","year":"2011","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.11.079","article-title":"Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection","volume":"21","author":"Amores-Iniesta","year":"2017","journal-title":"Cell Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500530","article-title":"Bacterial RNA: An Underestimated Stimulus for Innate Immune Responses","volume":"195","author":"Eigenbrod","year":"2015","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41467-017-02645-3","article-title":"Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1\u03b2 secretion","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4310816","DOI":"10.1155\/2018\/4310816","article-title":"Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells","volume":"2018","author":"Erdei","year":"2018","journal-title":"Oxid Med Cell Longevity"},{"key":"B22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s41232-018-0085-6","article-title":"Amyloid \u03b2 directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system","volume":"38","author":"Nakanishi","year":"2018","journal-title":"Inflammation Regeneration"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.immuni.2012.06.013","article-title":"Cell volume regulation modulates NLRP3 inflammasome activation","volume":"37","author":"Compan","year":"2012","journal-title":"Immunity"},{"key":"B27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.it.2018.01.009","article-title":"Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes","volume":"39","author":"Gong","year":"2018","journal-title":"Trends Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12079-017-0396-4","article-title":"Lysosomal destabilization activates the NLRP3 inflammasome in human umbilical vein endothelial cells (HUVECs)","volume":"11","author":"Kinnunen","year":"2017","journal-title":"J Cell Commun Signaling"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301490","article-title":"Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation","volume":"191","author":"Heid","year":"2013","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.565924","article-title":"Priming is dispensable for NLRP3 inflammasome activation in human monocytes","author":"Gritsenko","year":"2020","journal-title":"bioRxiv"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-146720","article-title":"Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages","volume":"113","author":"Netea","year":"2009","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M806121200","article-title":"Crystal structure of procaspase-1 zymogen domain reveals insight into inflammatory caspase autoactivation","volume":"284","author":"Elliott","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/s41467-020-16043-9","article-title":"N-GSDMD trafficking to neutrophil organelles facilitates IL-1\u03b2 release independently of plasma membrane pores and pyroptosis","volume":"11","author":"Karmakar","year":"2020","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000803","article-title":"Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia","volume":"185","author":"Lamkanfi","year":"2010","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","author":"Schiraldi","year":"2012","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nature11351","article-title":"Rapid induction of inflammatory lipid mediators by the inflammasome in vivo","volume":"490","author":"von Moltke","year":"2012","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545655","article-title":"NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5","volume":"45","author":"Baker","year":"2015","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","article-title":"Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes","volume":"62","author":"Lee","year":"2013","journal-title":"Diabetes"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00638-z","article-title":"CAPS and NLRP3","volume":"39","author":"Booshehri","year":"2019","journal-title":"J Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"116593","DOI":"10.1016\/j.lfs.2019.116593","article-title":"Inflammasome as a promising therapeutic target for cancer","volume":"231","author":"Lee","year":"2019","journal-title":"Life Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00276","article-title":"NLRP3 Inflammasome and Inflammatory Bowel Disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118790","article-title":"Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever","volume":"108","author":"Hoffman","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.05.005","article-title":"Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity","volume":"30","author":"Brydges","year":"2009","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.04.012","article-title":"A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses","volume":"30","author":"Meng","year":"2009","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"New Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis","volume":"118","author":"Brennan","year":"2008","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","first-page":"ii3","DOI":"10.1093\/rheumatology\/keg326","article-title":"The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis","author":"Dayer","year":"2003","journal-title":"Rheumatol (Oxford)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.08.010","article-title":"Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts","volume":"65","author":"Zhang","year":"2015","journal-title":"J Autoimmun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"110542","DOI":"10.1016\/j.biopha.2020.110542","article-title":"Role of the NLRP3 inflammasome in autoimmune diseases","volume":"130","author":"Li","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-41171-2_11","article-title":"Inflammasomes in Pneumococcal Infection: Innate Immune Sensing and Bacterial Evasion Strategies","volume":"397","author":"Rabes","year":"2016","journal-title":"Curr Top Microbiol Immunol"},{"key":"B57","unstructured":"Kineret (anakinra) Initial U.S. Approval"},{"key":"B58","unstructured":"Arcalyst (Rilonacept) Initial U.S"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03958.x","article-title":"Rilonacept and canakinumab","volume":"71","author":"Dubois","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"B60","unstructured":"Ilaris (Canakinumab) Initial U.S. Approval"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J Exp Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2219","article-title":"Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes","volume":"35","author":"Cavelti-Weder","year":"2012","journal-title":"Diabetes Care"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2016.09.017","article-title":"Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I\/II Clinical Trial","volume":"172","author":"Knickelbein","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-014-9623-6","article-title":"Population pharmacokinetic modeling of LY2189102 after multiple intravenous and subcutaneous administrations","volume":"16","author":"Bihorel","year":"2014","journal-title":"AAPS J"},{"key":"B66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J Cell Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010193431601","article-title":"Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus","volume":"343","author":"Langer","year":"2000","journal-title":"N Engl J Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/S1063-4584(03)00153-5","article-title":"Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis","volume":"11","author":"Rudolphi","year":"2003","journal-title":"Osteoarthritis Cartilage"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.111344","article-title":"(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme\/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18","volume":"321","author":"Wannamaker","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/ar3430","article-title":"A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee","volume":"13","author":"Cohen","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B73","first-page":"1","article-title":"Interleukin 1 Inhibitors","volume-title":"Encyclopedia of Inflammatory Diseases","author":"Pile","year":"2015"},{"key":"B74","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1186\/ar4303","article-title":"Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases","volume":"15","author":"Ottaviani","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090074","article-title":"Anakinra for rheumatoid arthritis: a systematic review","volume":"36","author":"Mertens","year":"2009","journal-title":"J Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/art.10870","article-title":"Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial","volume":"48","author":"Fleischmann","year":"2003","journal-title":"Arthritis Rheumatism"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081898","article-title":"Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases","volume":"20","author":"Bettiol","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02602","article-title":"Port d\u2019Entree for Respiratory Infections - Does the Influenza A Virus Pave the Way for Bacteria","volume":"8","author":"Siemens","year":"2017","journal-title":"Front Microbiol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00058-05","article-title":"Insights into the interaction between influenza virus and pneumococcus","volume":"19","author":"McCullers","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11064","article-title":"Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease-Modifying Antirheumatic Drugs","volume":"1","author":"Ozen","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113555","article-title":"Blood\u2013Brain Barrier Pathology and CNS Outcomes in Streptococcus pneumoniae Meningitis","volume":"19","author":"Yau","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/1471-2334-13-358","article-title":"Inflammasome activation mediates inflammation and outcome in humans and mice with pneumococcal meningitis","volume":"13","author":"Geldhoff","year":"2013","journal-title":"BMC Infect Dis"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1001191","DOI":"10.1371\/journal.ppat.1001191","article-title":"Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4","volume":"6","author":"McNeela","year":"2010","journal-title":"PLoS Pathog"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100790","article-title":"The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release","volume":"187","author":"Hoegen","year":"2011","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B87","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrmicro1871","article-title":"The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease","volume":"6","author":"Kadioglu","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003143","article-title":"The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia","volume":"187","author":"Witzenrath","year":"2011","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e0137108","DOI":"10.1371\/journal.pone.0137108","article-title":"Serotype 1 and 8 Pneumococci Evade Sensing by Inflammasomes in Human Lung Tissue","volume":"10","author":"Fatykhova","year":"2015","journal-title":"PloS One"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401624","article-title":"Neutrophil IL-1\u03b2 processing induced by pneumolysin is mediated by the NLRP3\/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux","volume":"194","author":"Karmakar","year":"2015","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02104-14","article-title":"The Interleukin-1\u03b2\/CXCL1\/2\/Neutrophil Axis Mediates Host Protection against Group B Streptococcal Infection","volume":"82","author":"Biondo","year":"2014","journal-title":"Infect Immun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2020.05.006","article-title":"The role of myeloid cells in prevention and control of group A streptococcal infections","volume":"2","author":"Matsumura","year":"2020","journal-title":"Biosafety Health"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00224-15","article-title":"Sensing of interleukin-1 cytokines during Streptococcus pneumoniae colonization contributes to macrophage recruitment and bacterial clearance","volume":"83","author":"Lemon","year":"2015","journal-title":"Infect Immun"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.04.004","article-title":"NLRP3\/ASC\/Caspase-1 axis and serine protease activity are involved in neutrophil IL-1\u03b2 processing during Streptococcus pneumoniae infection","volume":"513","author":"Zhang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B95","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23\u2013IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03240.x","article-title":"Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease","volume":"129","author":"Onishi","year":"2010","journal-title":"Immunology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2016.113","article-title":"Neutrophilic NLRP3 inflammasome-dependent IL-1beta secretion regulates the gammadeltaT17 cell response in respiratory bacterial infections","volume":"10","author":"Hassane","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36731","article-title":"Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice","volume":"119","author":"Zhang","year":"2009","journal-title":"J Clin Invest"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100381","article-title":"Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection","volume":"187","author":"Fang","year":"2011","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B100","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1038\/s41467-019-11169-x","article-title":"Hydrogen peroxide release by bacteria suppresses inflammasome-dependent innate immunity","volume":"10","author":"Erttmann","year":"2019","journal-title":"Nat Commun"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00393.2017","article-title":"NLRP3 inflammasome activation in aged macrophages is diminished during Streptococcus pneumoniae infection","volume":"314","author":"Cho","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00618-13","article-title":"Impaired innate mucosal immunity in aged mice permits prolonged Streptococcus pneumoniae colonization","volume":"81","author":"Krone","year":"2013","journal-title":"Infect Immun"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1412487111","article-title":"Human NLRP3 inflammasome senses multiple types of bacterial RNAs","volume":"111","author":"Sha","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C114.548982","article-title":"RNA and \u03b2-hemolysin of group B Streptococcus induce interleukin-1\u03b2 (IL-1\u03b2) by activating NLRP3 inflammasomes in mouse macrophages","volume":"289","author":"Gupta","year":"2014","journal-title":"J Biol Chem"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000513","article-title":"Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19","volume":"205","author":"Yap","year":"2020","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"21288","DOI":"10.1038\/srep21288","article-title":"Differential neutrophil responses to bacterial stimuli: Streptococcal strains are potent inducers of heparin-binding protein and resistin-release","volume":"6","author":"Snall","year":"2016","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.614801\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T06:40:56Z","timestamp":1607928056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.614801\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":106,"alternative-id":["10.3389\/fimmu.2020.614801"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.614801","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"article-number":"614801"}}